文献速递血栓与止血

极端血小板增多症与住院儿科患者的重症和低龄相关,但不增加血栓风险

Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients.
PubMed 文献 · J Thromb Haemost · 2020-10-21

该研究回顾性分析单中心约8万儿科患者8年数据,发现极端血小板增多症(血小板计数>1000×10^3/μL)几乎均为继发性(99.8%),多发生于2岁以下(47%)和/或重症(55%),无直接归因于极端血小板增多症的血栓或出血事件。

要点

  • 住院儿科极端血小板增多症几乎均为继发性(99.8%),多因素致病。
  • 47%的病例发生于2岁以下儿童,55%发生于重症期间。
  • 无血栓或出血事件直接归因于极端血小板增多症。

核心结论

  • 儿科患者中与极端血小板增多症相关的血栓事件罕见,可为经验性抗血小板治疗的使用提供参考。

研究设计与样本

  • 回顾性分析单中心儿科队列约80 000例患者8年间的极端血小板增多症病例。

主要发现

  • 几乎所有病例(99.8%)为继发性,且多数为多因素致病。
  • 许多病例发生于2岁以下儿童(47%)和/或重症期间(55%)。
  • 无血栓或出血事件直接由极端血小板增多症导致。
  • 有迹象表明新生儿造血和个体遗传变异影响部分病例,某些诊断(如镰状细胞贫血)和临床背景(如无脾)也有影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extreme thrombocytosis (EXT, platelet count > 1000 × 103 /μL) is an uncommon but potentially clinically significant finding. Primary EXT in the setting of myeloproliferative disorders is linked to thrombotic and/or bleeding complications more frequently than secondary EXT, which typically occurs in reaction to infection, inflammation, or iron deficiency. However, comorbidities have been reported in adults with secondary EXT. Clinical implications of EXT in children are not well defined, as prior studies targeted small and/or specialized pediatric populations. OBJECTIVES: Our objectives were to determine etiologies and sequelae of EXT in a hospitalized general pediatric patient population. PATIENTS AND METHODS: We retrospectively analyzed EXT cases from a single-center pediatric cohort of ~80 000 patients over 8 years. RESULTS: Virtually all cases (99.8%) were secondary in nature, and most were multifactorial. Many cases of EXT occurred in children under 2 years old (47%) and/or during critical illness (55%). No thrombotic or bleeding events directly resulted from EXT, confirming a paucity of clinical complications associated with EXT in pediatric patients. There were indications that neonatal hematopoiesis and individual genetic variation influenced some cases, in addition to certain diagnoses (eg, sickle cell anemia) and clinical contexts (eg, asplenia). CONCLUSION: Our findings confirm that thrombotic events related to EXT are rare in pediatric patients, which can inform the use of empiric anti-platelet therapy.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Thom CS, Echevarria E, Osborne AD, et al. Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients. J Thromb Haemost. 2020. PMID: 32979018. doi:10.1111/jth.15103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。